BSE filing, NSE: VENUSREM. Summary written from the filing by ALFA Finder's alert engine.
Venus Remedies Ltd: key numbers
- Share price
- ₹1,447.90
- Market cap
- ₹1,935 Cr
- Revenue (annual)
- ₹769.6 Cr
- Net profit (annual)
- ₹102.8 Cr
- P/E (TTM)
- 15.9×Sector 43.8×
- Promoter holding
- 41.76%+0.00% QoQ
- FII holding
- 3.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venus Remedies Ltd
All →Venus Remedies Q2 FY27 Results: Net Profit ₹25.6 Cr, Up 27.4% YoY
Venus Remedies Ltd reported revenue from operations of ₹218.8 Cr (+13.5% YoY) and net profit of ₹25.6 Cr (+27.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹25.6 Cr · +27.4% YoY
Venus Remedies Regulatory Approval
Venus Remedies Limited secured five marketing authorizations for drugs including Vancomycin and Meropenem across Kazakhstan, Peru, Kuwait, and Argentina. These regulatory approvals expand its global pharmaceutical portfolio.
Venus Remedies Board Meeting Date
Venus Remedies will hold a board meeting on 26th October 2026 to consider and approve its unaudited standalone and consolidated financial results for the September quarter.
Venus Remedies Other Announcement
Venus Remedies Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Venus Remedies Other Announcement
Venus Remedies Limited has announced a change in its Corporate Identification Number (CIN) following the alteration of its Memorandum of Association.
Venus Remedies Other Announcement
Venus Remedies Limited has informed the exchanges about its social media posts regarding a special window for the re-lodgement of physical share transfer requests.
Other other announcement announcements
All →Triveni Glass Other Announcement
Triveni Glass director Anil Kumar Dhawan bought 15,188 shares on BSE for Rs.1,43,992. Routine PIT Reg 7(2) disclosure by a non-promoter director.
- Value
- ₹0.01 Cr
GRE Renew Enertech Other Announcement
GRE Renew Enertech filed its Reg 32 quarterly statement on IPO proceeds utilisation. It reports a reallocation of funds from solar plant capex to general corporate purposes.
Vectras Enprocon Other Announcement
Director Ravi P Patel bought 12,000 Vectras Enprocon shares for Rs. 0.13 Crore on BSE. No promoter involvement in this routine market purchase.
- Value
- ₹0.13 Cr
LGT Global Hospitality Other Announcement
LGT Global Hospitality filed its quarterly Monitoring Agency Report for Q1 FY27 under ICDR 162A. The report confirms Nil deviation in utilisation of its ₹21.92 crore IPO proceeds.
Astra Microwave Products Other Announcement
Astra Microwave filed a Reg 32 statement for the quarter ended September 30, 2026. It confirms no deviation or variation in the use of preferential-issue warrant proceeds.
Rane Holdings Other Announcement
Rane Holdings filed its Q1 FY27 Reg 32 statement on use of preferential-warrant proceeds. It reported ₹10 Cr raised and ₹7.81 Cr utilised for borrowings, with no deviation.